TD Cowen Raises TransMedics Group (NASDAQ:TMDX) Price Target to $175.00

TransMedics Group (NASDAQ:TMDX – Free Report) had its target price boosted by TD Cowen from $130.00 to $175.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the stock. Other analysts also recently issued reports about the company. JPMorgan Chase & Co. raised their […]

Leave a Reply

Your email address will not be published.

Previous post David Duchovny’s ‘Reverse the Curse’ about more than baseball
Next post Empire State Realty OP (NYSE:ESBA) Coverage Initiated at StockNews.com